In disagreeing with the FDA’s statement, Edelman said Lexicon had a risk mitigation strategy centered on educating both health care professionals and people with type 1 diabetes about DKA that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback